Equities

Manolete Partners PLC

Manolete Partners PLC

Actions
  • Price (USD)1.50
  • Today's Change0.00 / 0.00%
  • Shares traded8.12k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Feb 23 2024 19:12 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Manolete Partners PLC is a United Kingdom-based insolvency litigation financing company. The principal activity of the Company is that of acquiring and funding insolvency litigation cases. The Company has invested in over 830 United Kingdom insolvency litigation cases and completed over 590 of them. It works alongside Insolvency Practitioners (IPs) from larger to smaller regional firms. It has worked with over 200 IP firms and their chosen legal advisers, often on multiple cases. The Company works with insolvency solicitor firms and barrister chambers in the United Kingdom insolvency market. The Company's insolvency practitioner and their lawyers make optimal recoveries for the creditor estates and take on all the risk.

  • Revenue in GBP (TTM)26.47m
  • Net income in GBP1.94m
  • Incorporated2011
  • Employees25.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.